Dr. Ji Hye Son, MD

Dr. Son practices at PIH Health Physicians in Whittier, California.

Dr. Son's NPI, 1124361803, was assigned on April 1, 2013. Dr. Son graduated from Stanford University School Of Medicine in 2013. Dr. Son holds California license A159983.

Dr. Son's primary practice is PIH Health Physicians, at 12522 E Lambert Rd, Whittier, CA 90606 in Los Angeles County. The practice phone is (562) 789-5420.

Dr. Son's primary practice is PIH Health Physicians in Whittier, California. Dr. Son is also affiliated with PIH Health Whittier Hospital. The medical group on file is PIH Health Physicians. Dmand AI also links Dr. Son to 2 more hospitals, 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Son practices, 5 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Son's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Son is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Son's licenses on file in 2 states: California and Ohio.

Dmand AI lists breast reconstruction and removal of damaged skin or skin graft among the conditions Dr. Son treats.

CMS data shows 15 Medicare services from Dr. Son across 1 procedure code in 2024, all of them office visits, for 30 Medicare patients. Medicare paid $1,461 for them. Every service was in an office.

CMS counts 30 Medicare patients who saw Dr. Son in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 37% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Son's median patient age at 58, with 66% women.

In 2024, Dr. Son wrote 58 Medicare Part D claims for 27 patients. 93% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $496 in total drug cost. In 2023, CMS named 64 claims across 4 drugs.

Dr. Son accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 36 procedures of melanoma (skin cancer) excision by Dr. Son, more than 83% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Son, published from 2017 to 2020. 2017 was the busiest year, with 3. The most frequent topics are Skin Aging. Dr. Son has published most often in Aesthetic Plast Surg. Dr. Son's most frequent co-authors are Bahman Guyuron, MD, Hooman T. Soltanian, MD and Devra Beyer Becker, MD.

CMS Open Payments shows 21 general payments to Dr. Son from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 56% of the total. Allergan Inc. paid the most, $1,372.

Dr. Son graduated from Stanford University School Of Medicine in 2013.

Dr. Son is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.